Sept 19 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL ANNOUNCES PUBLIC DISCLOSURE: REMARKABLE RESPONDER IN COMBINATION STUDY OF LEAD CANDIDATE WITH KEYTRUDA®
* BRIACELL THERAPEUTICS CORP - DATA PRESENTED TODAY ALSO NOTED THAT BRIA-IMT REGIMEN ADMINISTERED WITH KEYTRUDA WAS SAFE AND WELL TOLERATED